Short Interest in Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Grows By 125.9%

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,100 shares, a growth of 125.9% from the November 30th total of 2,700 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.1% of the company's shares are sold short.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a "buy" rating and issued a $7.00 target price on shares of Armata Pharmaceuticals in a research report on Thursday, December 19th.

Armata Pharmaceuticals Stock Performance

Shares of ARMP stock traded up $0.09 during trading hours on Friday, reaching $2.11. 6,022 shares of the company's stock were exchanged, compared to its average volume of 12,283. Armata Pharmaceuticals has a 1 year low of $1.85 and a 1 year high of $4.48. The firm has a market capitalization of $76.34 million, a price-to-earnings ratio of -1.29 and a beta of 0.78.

About Armata Pharmaceuticals

Armata Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.